成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 419572-18-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 419572-18-2
Chemical Structure| 419572-18-2
Structure of 419572-18-2 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 419572-18-2 ]

Related Doc. of [ 419572-18-2 ]

Alternatived Products of [ 419572-18-2 ]
Product Citations

Product Details of [ 419572-18-2 ]

CAS No. :419572-18-2 MDL No. :MFCD14525755
Formula : C11H19NO3 Boiling Point : -
Linear Structure Formula :- InChI Key :JVIDPFGQYMFQDZ-JVHMLUBASA-N
M.W : 213.27 Pubchem ID :49757489
Synonyms :

Calculated chemistry of [ 419572-18-2 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.91
Num. rotatable bonds : 4
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 60.45
TPSA : 49.77 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.07 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.67
Log Po/w (XLOGP3) : 0.75
Log Po/w (WLOGP) : 0.71
Log Po/w (MLOGP) : 1.15
Log Po/w (SILICOS-IT) : 0.52
Consensus Log Po/w : 1.16

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.37
Solubility : 9.08 mg/ml ; 0.0426 mol/l
Class : Very soluble
Log S (Ali) : -1.37
Solubility : 9.0 mg/ml ; 0.0422 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.64
Solubility : 48.6 mg/ml ; 0.228 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.99

Safety of [ 419572-18-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 419572-18-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 419572-18-2 ]

[ 419572-18-2 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 419572-18-2 ]
  • [ 4214-79-3 ]
  • C16H21ClN2O3 [ No CAS ]
YieldReaction ConditionsOperation in experiment
With dibenzyl azodicarboxylate; triphenylphosphine; In tetrahydrofuran; at 20℃;Product distribution / selectivity; In a flame-dried flask under N2, was combined 807 mg (6.24 mmol, 1.33 eq) of 5- chloro 2-pyridyl phenol and 1.64 g (6.23 mmol, 1.33 eq) of triphenylphosphine in 20 mL of anhydrous THF at room temperature. To this solution was added 1.86 g (6.233 mmol, 1.33 eq) of DBAD, followed by 1.0 g (4.69 mmol, 1.0 eq) of 6-hydroxymethyl-3-aza- <n="58"/>bicyclo[3.1.0]hexane-3-carboxylic acid tert-butyl ester in 5 ml_ of anhydrous THF. The yellow solution was stirred at room temperature overnight. To this solution was added 6.3 mL (25.2 mmol, 5.4 eq) of 4M HCI in 1 ,4-dioxane and the resulting solution was stirred at room temperature overnight. The solution was concentrated under reduced pressure and the resulting residue was dissolved in 95 mL methylene chloride. The solution was extracted with 63 mL of 15percent aqueous citric acid. The aqueous layer was extracted with 95 mL of methylene chloride. The aqueous layer was basified with 32 mL of cone. NH4OH and extracted three times with 65 mL of methylene chloride. The combined organic layers were dried over anhydrous MgSO4, filtered and stripped in vacuo to give yellow oil which crystallized while drying under high vaccum (588 mg). The crude material was purified via flash chromatography, eluting with 5percent methanol/ methylene chloride- with 0.1 percent triethyl amine to yield 242 mg of desired compound. 400 MHz 1H NMR (CDCI3) delta 8.0 (d, 1 H), 7.5 (m, 1H), 6.7 (d, 1 H), 4.1 (d, 2H), 3.1 (d, 2H), 2.9-3.0 (m, 3H), 1.5 (m, 2H), 1.2 (m, 1H); MS (M+1) 225, 227.
With triphenylphosphine; diethylazodicarboxylate; In tetrahydrofuran; at 20℃; for 64h;Product distribution / selectivity; 19.5 mmol of triphenyl phosphine was dissolved in 9.75 mL of anhydrous THF and vortexed. 75 mul (0.15 mmol) of this solution was added to each 0.1 mmol of varying phenols of general foumula (III) in 2-dram vials. 13.0 mmol of (1S,5R,6R)-tert-butyl 6-(hydroxymethyl)-3- <n="59"/>aza-bicycio[3.1.0]hexane-3-carboxylate (Preparation 1 ) was dissolved in 6.5 mL of anhydrous THF and vortexed. 50 muL (0.10 mmol) of this solution was added to each vial. 19.5 mmol of Diethylazodicarboxylate (DEAD) was dissolved in 9.75 mL of anhydrous THF and vortexed. 75 muL (0.15 mmol) of this solution was added to each vial. The vials were sealed and placed on shaker at room temperature for 64 hours. 200 muL of 4 M HCI in 1 ,4-dioxane was then added to each vial and the vials were placed on a shaker at room temperature for 16 hours. The reactions were evaporated under nitrogen. MCX SPE columns were conditioned by eluting twice with 4 mL of CH3OH. The reaction residues were dissolved with 1.0 mL of CH3OH, vortexed, and the reaction residues were added to the MCX columns. The reaction vials were rinsed two times with 1.0 mL of CH3OH, vortexed, and the reaction residues were added to the columns. The columns were eluted three times with 4.0 mL of CH3OH. 4.0 mL of 2 M NH3 in CH3OH was added to each vial with the eluent collected in tared 2-dram vials. The vials were evaporated under nitrogen, tared, and used without further purification in the next reaction. To each of the vials prepared above were added 500 muL of 1 ,2-dichloroethane and 28 muL (0.2 mmol) of triethylamine. 4.3 mmol of an aldehyde of general formula (V) was dissolved in 4.3 mL of 1 ,2-dichloroethane and 0.1 mL (0.1 mmol) was added to the vials. 0.3 mmol of sodium triacetoxyborohydride was added to vials. The vials were sealed and placed on shaker at room temperature for 16 hours. 1.5 mL of 1 N NaOH, followed by 1.0 mL of 1 ,2- dichloroethane was added to each vial and vortexed for 4 minutes. The layers were allowed to separate and 1.5 mL was removed from the lower layer to empty SPE barrels, which were allowed to drip into tared 2-dram vials. 1.0 mL of 1 ,2-dichloroethane was added and the mixture was vortexed for 4 minutes. The layers were allowed to separate and 1 mL was removed from the lower layer to empty SPE barrels, which were allowed to drip into the tared 2-dram vials. 1.0 mL of 1 ,2-dichloroethane was added to the each vial and vortexed for 4 minutes. The layers were allowed to separate and 1 mL was removed from the lower layer to empty SPE barrels, which were allowed to drip into tared 2-dram vials. The combined SPE eluents remaining in the 2 dram tared vials were evaporated in a Savant SpeedVac Plus. The resulting crude mixtures were purified via preparative LC/MS chromatography to yield compounds of general formula (Vl).Alternatively, compounds of formula I can be prepared as highlighted below in method C, utilizing parallel chemistry or high-speed synthesis methods.
With triphenylphosphine on polystyrene; diethylazodicarboxylate; In tetrahydrofuran; toluene; at 20℃; for 17h;Product distribution / selectivity; Prepared a 2 M stock solution of (1S,5R,6R)-tert-butyl 6-(hydroxymethyl)-3-aza- bicyclo[3.1.0]hexane-3-carboxyiate (Preparation 1 ) in THF. Prepared 2 M stock solutions of varying phenols of a general formula (III) <n="60"/>in THF. Prepared a 0.5 M stock solution of DEAD in toluene. To each reaction vial, added 0.200 ml_ of the varying phenol followed by 0.075 mL of (1S,5R,6R)-tert-butyl 6- (hydroxymethyl)-3-aza-bicyclo[3.1.0]hexane-3-carboxylate. Added 0.600 mL of the DEAD solution, followed by 0.750 mL of toluene. Added 140 mg of triphenylphosphine-polystyrene resin. Vials were capped and shaken at room temperature for 17 hours. Added 2.5 mL of THF to each reaction vial. The top layer was transferred to empty 6 mL SPE cartridges over collection tubes. Added 3.0 mL of THF to the reaction vials and then aspirated the top layer to the SPE cartridges over collection tubes. Transferred solutions from collection tubes to new reaction vials and evaporated. Added 0.600 mL of CH3OH followed by 0.300 mL of 4 M HCI in 1 ,4-dioxane to each reaction vial. Vials were capped and shaken at room temperature for 24 hours. The solvent was evaporated and the intermediates used without further purification in the next reaction.Prepared a 0.25 M solution of an aldehyde of general formula (V) in 1 ,2- dichloroethane. Prepared a 0.25 M solution of sodium triacetoxyborohydride in 1 ,2- dichloroethane. Added 0.600 mL of the aldehyde solution to each of the reaction vials from the step above, followed by 0.070 mL of DIPEA. Added 2.0 mL of the sodium triacetoxyborohydride solution, capped vials and shaken at room temperature for 17 hours. Added 1.0 mL of 1 ,2-dichloroethane followed by 2.0 mL of 10percent NaOH. Vials were vortexed and/or shaken and removed top layer. Added 2.0 mL of 10percent NH4OH, with vials shaken well and/ or vortexed. The bottom layers were aspirated to empty 6 mL SPE cartridges over tared collection tubes. Added 1.0 mL of 1 ,2-dichloroethane to the aqueous layer and aspirated the bottom layer to the SPE cartridge over the collection tubes. Evaporated solutions to dryness. The resulting crude mixtures were purified via preparative LC/MS chromatography to yield compounds of general formula (Vl) Alternatively, compounds of formula I can be prepared as highlighted below in method D utilizing parallel chemistry or high-speed synthesis methods.
With triphenylphosphine on polystyrene; di-tert-butyl-diazodicarboxylate; In tetrahydrofuran; at 20℃; for 1h;Product distribution / selectivity; Prepared a 2 M stock solution of (1S,5R,6R)-tert-butyl 6-(hydroxymethyl)-3-aza- bicyclo[3.1.0]hexane-3-carboxylate (Preparation 1) in THF. Prepared 2 M stock solutions of varying phenols of a general formula (III) in THF. Prepared a 2 M stock solution of DBAD (di-t- butylazodicarboxylate) in THF. To each reaction vial, added 0.075 mL of the varying phenol followed by 0.075 mL of 2 M solution of triphenylphosphine in THF. The prepared solutions of (1S,5R,6R)-tert-butyl 6-(hydroxymethyl)-3-aza-bicyclo[3.1.0]hexane-3-carboxylate and DBAD were mixed in 3:4 ratio and 0.1313 mL of this mixture was added to each reaction vial. Vials are capped and shaken at room temperature for 1 hour. Added 0.15 mL of 4 M HCI in 1 ,4- dioxane to each reaction vial. Vials are capped and shaken at room temperature for 16 hours. The solvent was evaporated and to each vial was added 3 mL of dichloromethane and 2 mL <n="61"/>of 15percent aqueous citric acid solution. The vials were shaken and centrifuged followed by removal of the lower organic layer. 3 mL of dichloromethane was added too each via) and the vials were shaken and centrifuged followed by removal of the lower organic layer. The last operation was repeated. To each vial was added 2 mL of 28percent aqueous NH4OH. After cooling, 2 mL of dichloromethane was added. The vials were shaken and centrifuged followed by collecting of the lower organic layer. The solvent was evaporated and the obtained products were used in the next step without further purification.Prepared a 0.25 M solution of an aldehyde of general formula (V) in 1 ,2- dichloroethane. Prepared a 0.25 M solution of sodium triacetoxyborohydride in chloroform. To each vial from the step above was added 0.45 mL of 1 ,2-dichoroethane and, following dissolution, 0.45 mL of the aldehyde followed by 1.51 mL of the sodium triacetoxyborohydride solution. The vials were capped and shaken at room temperature for 17 hours. To each vial was added 2 mL of 10percent aqueous NaOH. Vials were shaken and centrifuged followed by transfer of the lower organic layer to phase separation cartridges. Organic layer was collected and the solvent was removed by evaporation. The resulting crude mixtures were purified via preparative LC/MS chromatography to yield compounds of general formula (Vl).Alternatively, compounds of formula I can be prepared as highlighted below in method E, utilizing parallel chemistry or high-speed synthesis methods.

Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 419572-18-2 ]

Alcohols

Chemical Structure| 140695-85-8

[ 140695-85-8 ]

(R)-tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.94

Chemical Structure| 116574-71-1

[ 116574-71-1 ]

tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.94

Chemical Structure| 140695-84-7

[ 140695-84-7 ]

tert-Butyl (S)-3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.94

Chemical Structure| 146667-84-7

[ 146667-84-7 ]

tert-Butyl 3-(2-hydroxyethyl)piperidine-1-carboxylate

Similarity: 0.94

Chemical Structure| 123855-51-6

[ 123855-51-6 ]

tert-Butyl 4-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.94

Amides

Chemical Structure| 140695-85-8

[ 140695-85-8 ]

(R)-tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.94

Chemical Structure| 116574-71-1

[ 116574-71-1 ]

tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.94

Chemical Structure| 140695-84-7

[ 140695-84-7 ]

tert-Butyl (S)-3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.94

Chemical Structure| 146667-84-7

[ 146667-84-7 ]

tert-Butyl 3-(2-hydroxyethyl)piperidine-1-carboxylate

Similarity: 0.94

Chemical Structure| 236406-39-6

[ 236406-39-6 ]

8-Boc-2,8-Diazaspiro[4.5]decane

Similarity: 0.94

Related Parent Nucleus of
[ 419572-18-2 ]

Aliphatic Heterocycles

Chemical Structure| 140695-85-8

[ 140695-85-8 ]

(R)-tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.94

Chemical Structure| 116574-71-1

[ 116574-71-1 ]

tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.94

Chemical Structure| 140695-84-7

[ 140695-84-7 ]

tert-Butyl (S)-3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.94

Chemical Structure| 146667-84-7

[ 146667-84-7 ]

tert-Butyl 3-(2-hydroxyethyl)piperidine-1-carboxylate

Similarity: 0.94

Chemical Structure| 236406-39-6

[ 236406-39-6 ]

8-Boc-2,8-Diazaspiro[4.5]decane

Similarity: 0.94

Other Aliphatic Heterocycles

Chemical Structure| 273206-92-1

[ 273206-92-1 ]

rel-(1R,5S,6s)-tert-Butyl 6-amino-3-azabicyclo[3.1.0]hexane-3-carboxylate

Similarity: 0.92

Chemical Structure| 663172-78-9

[ 663172-78-9 ]

N-Boc-6-hydroxy-3-azabicyclo[3.2.0]heptane

Similarity: 0.91

Chemical Structure| 1187933-06-7

[ 1187933-06-7 ]

tert-Butyl hexahydro-1H-pyrrolo[3,4-c]pyridine-5(6H)-carboxylate hydrochloride

Similarity: 0.90

Chemical Structure| 203663-25-6

[ 203663-25-6 ]

tert-Butyl 5-hydroxyhexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate

Similarity: 0.90

Chemical Structure| 1588507-46-3

[ 1588507-46-3 ]

cis-tert-Butyl octahydropyrrolo[3,4-d]azepine-2(1H)-carboxylate hydrochloride

Similarity: 0.90

; ;